Cargando…
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
BACKGROUND: The recent global pandemic has placed a high priority on identifying drugs to prevent or lessen clinical infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused by Coronavirus disease-2019 (COVID-19). METHODS: We applied two computational approaches to identify...
Autores principales: | Kim, Jason, Zhang, Jenny, Cha, Yoonjeong, Kolitz, Sarah, Funt, Jason, Escalante Chong, Renan, Barrett, Scott, Kusko, Rebecca, Zeskind, Ben, Kaufman, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315012/ https://www.ncbi.nlm.nih.gov/pubmed/32586380 http://dx.doi.org/10.1186/s12967-020-02430-9 |
Ejemplares similares
-
Leveraging existing data sets to generate new insights into Alzheimer’s disease biology in specific patient subsets
por: Fowler, Kevin D., et al.
Publicado: (2015) -
Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse
por: Kusko, Rebecca, et al.
Publicado: (2018) -
Pridopidine activates neuroprotective pathways impaired in Huntington Disease
por: Geva, Michal, et al.
Publicado: (2016) -
Letter to the Editor response: Nygaard et al.
por: Towfic, F., et al.
Publicado: (2017) -
Response to the Letter-to-the Editor by Cohen et al. concerning our eNeurologicalSci article, Melamed-Gal, et al. Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone. eNeurologicalSci 2018;12:19–30.https://doi.org/10.1016/j.ensci.2018.05.006
por: Melamed-Gal, Sigal, et al.
Publicado: (2018)